Mc Adam, LLC Abb Vie Inc. Transaction History

Mc Adam, LLC

$1.77 Billion
Q3 2024

A detailed history of Mc Adam, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Mc Adam, LLC holds 17,377 shares of ABBV stock, worth $3.05 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

17,377

Previous 17,221 0.91%

Holding current value

$3.05 Million

Previous $2.95 Million 16.19%

% of portfolio

0.19%

Previous 0.18%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$163.84 - $199.33 $25,559 - $31,095	156 Added 0.91%	17,377 $3.43 Million
Q2 2024 Jul 24, 2024	BUY	$154.79 - $180.76 $20,741 - $24,221	134 Added 0.78%	17,221 $2.95 Million
Q1 2024 Apr 23, 2024	SELL	$159.82 - $182.1 $958 - $1,092	-6 Reduced 0.04%	17,087 $3.11 Million
Q4 2023 Feb 05, 2024	SELL	$137.6 - $154.97 $31,235 - $35,178	-227 Reduced 1.31%	17,093 $2.65 Million
Q3 2023 Oct 31, 2023	BUY	$133.59 - $154.65 $29,256 - $33,868	219 Added 1.28%	17,320 $2.58 Million
Q2 2023 Aug 02, 2023	SELL	$132.51 - $164.9 $560,119 - $697,032	-4,227 Reduced 19.82%	17,101 $2.3 Million
Q1 2023 Apr 24, 2023	BUY	$144.61 - $166.54 $847,559 - $976,090	5,861 Added 37.89%	21,328 $3.4 Million
Q4 2022 Jan 27, 2023	SELL	$138.31 - $165.87 $219,912 - $263,733	-1,590 Reduced 9.32%	15,467 $2.09 Million
Q3 2022 Oct 24, 2022	BUY	$134.21 - $153.93 $86,565 - $99,284	645 Added 3.93%	17,057 $2.29 Million
Q2 2022 Jul 15, 2022	BUY	$137.62 - $174.96 $120,417 - $153,090	875 Added 5.63%	16,412 $2.51 Million
Q1 2022 Apr 07, 2022	BUY	$131.98 - $163.75 $9,238 - $11,462	70 Added 0.45%	15,537 $2.52 Million
Q4 2021 Jan 07, 2022	BUY	$107.43 - $135.93 $2,685 - $3,398	25 Added 0.16%	15,467 $2.09 Million
Q3 2021 Oct 05, 2021	BUY	$106.4 - $120.78 $4,468 - $5,072	42 Added 0.27%	15,442 $1.67 Million
Q2 2021 Aug 02, 2021	BUY	$105.21 - $117.21 $688,389 - $766,905	6,543 Added 73.87%	15,400 $1.83 Million
Q1 2021 Apr 26, 2021	SELL	$102.3 - $112.62 $21,994 - $24,213	-215 Reduced 2.37%	8,857 $958,000
Q4 2020 Jan 12, 2021	BUY	$80.49 - $108.67 $18,512 - $24,994	230 Added 2.6%	9,072 $989,000
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $68,384 - $80,260	796 Added 9.89%	8,842 $774,000
Q2 2020 Jul 31, 2020	BUY	$73.37 - $98.18 $27,953 - $37,406	381 Added 4.97%	8,046 $790,000
Q1 2020 May 08, 2020	BUY	$64.5 - $97.79 $273,157 - $414,140	4,235 Added 123.47%	7,665 $584,000
Q4 2019 Jan 23, 2020	BUY	$72.13 - $90.25 $19,907 - $24,909	276 Added 8.75%	3,430 $304,000
Q3 2019 Oct 15, 2019	BUY	$62.98 - $75.72 $11,840 - $14,235	188 Added 6.34%	3,154 $239,000
Q2 2019 Jul 30, 2019	BUY	$65.7 - $83.98 $194,866 - $249,084	2,966 New	2,966 $216,000
Q1 2019 Apr 22, 2019	SELL	$77.14 - $90.79 $191,230 - $225,068	-2,479 Closed	0 $0
Q4 2018 Jan 30, 2019	BUY	$77.85 - $96.01 $14,480 - $17,857	186 Added 8.11%	2,479 $229,000
Q3 2018 Oct 10, 2018	SELL	$88.91 - $98.84 $39,920 - $44,379	-449 Reduced 16.37%	2,293 $216,000
Q2 2018 Aug 22, 2018	BUY	$89.78 - $106.23 $4,129 - $4,886	46 Added 1.71%	2,742 $254,000
Q1 2018 Apr 24, 2018	BUY	$92.01 - $123.21 $248,058 - $332,174	2,696 New	2,696 $255,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Adam, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Adam, LLC with notifications on news.

Account